Trial record 8 of 1204 for:    atrial fibrillation

A French Multi-centric Atrial Fibrillation Catheter Ablation Survey (FrenchAF)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
University Hospital of Grenoble, Grenoble, France
Nouvelle Clinique Nantaise, Nantes, France
Parly 2 Medical Surgical Center (CMC), Le Chesnay, France
Rennes University Hospital
University Hospital of Rouen, Rouen, France
Information provided by (Responsible Party):
Serge Boveda, Clinique Pasteur
ClinicalTrials.gov Identifier:
NCT01918670
First received: August 6, 2013
Last updated: NA
Last verified: August 2013
History: No changes posted
  Purpose

Atrial fibrillation is the most frequent sustained arrhythmia. Catheter ablation is a procedure that is currently used for the treatment of symptomatic atrial fibrillation patients.

We have organized a multi-centric national survey of catheter ablation of atrial fibrillation in order to have a feedback on the type of procedures being performed and the overall results (freedom of atrial fibrillation) over an average follow-up of 18 months.


Condition Intervention
Observation of Outcome After Catheter Ablation of Atrial Fibrillation
Procedure: catheter ablation of atrial fibrillation

Study Type: Observational [Patient Registry]
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 18 Months
Official Title: A French Multi-centric Atrial Fibrillation Catheter Ablation Survey

Resource links provided by NLM:


Further study details as provided by Clinique Pasteur:

Primary Outcome Measures:
  • Atrial fibrillation relapse [ Time Frame: starting 3 months after the procedure till an average of 18months follow-up ] [ Designated as safety issue: No ]
    Documentation of atrial fibrillation relapse (symptomatic or asymptomatic) after the first 3 months after the index procedure


Secondary Outcome Measures:
  • Early atrial fibrillation relapse [ Time Frame: first 3 months ] [ Designated as safety issue: No ]
    Documented atrial fibrillation relapse (symptomatic or asymptomatic) in the first 3 months after the index procedure


Study Start Date: November 2010
Estimated Study Completion Date: December 2013
Primary Completion Date: July 2013 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Pasteur Procedure: catheter ablation of atrial fibrillation
electric pulmonary vein disconnection
Grenoble Procedure: catheter ablation of atrial fibrillation
electric pulmonary vein disconnection
Nantes Procedure: catheter ablation of atrial fibrillation
electric pulmonary vein disconnection
Parly Procedure: catheter ablation of atrial fibrillation
electric pulmonary vein disconnection
Rennes Procedure: catheter ablation of atrial fibrillation
electric pulmonary vein disconnection
Rouen Procedure: catheter ablation of atrial fibrillation
electric pulmonary vein disconnection

  Eligibility

Ages Eligible for Study:   18 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

All patients undergoing catheter ablation in one of the registry centers

Criteria

Inclusion Criteria:

  • all patients undergoing catheter ablation of atrial fibrillation or left atrial flutter

Exclusion Criteria:

  • patients undergoing catheter ablation of other types of arrhythmia
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01918670

Locations
France
Clinique Pasteur
Toulouse, France
Sponsors and Collaborators
Clinique Pasteur
University Hospital of Grenoble, Grenoble, France
Nouvelle Clinique Nantaise, Nantes, France
Parly 2 Medical Surgical Center (CMC), Le Chesnay, France
Rennes University Hospital
University Hospital of Rouen, Rouen, France
  More Information

No publications provided

Responsible Party: Serge Boveda, MD, Clinique Pasteur
ClinicalTrials.gov Identifier: NCT01918670     History of Changes
Other Study ID Numbers: FrenchAFAblationSurvey
Study First Received: August 6, 2013
Last Updated: August 6, 2013
Health Authority: France: no authority.

Keywords provided by Clinique Pasteur:
atrial fibrillation; catheter ablation; relapse; stroke; death

Additional relevant MeSH terms:
Atrial Fibrillation
Arrhythmias, Cardiac
Heart Diseases
Cardiovascular Diseases
Pathologic Processes

ClinicalTrials.gov processed this record on August 21, 2014